Susan Eylward sold $3,830 of IMNN
General Counsel and Corp Sec at Imunon, Inc.. 2,150 shares at an average of $1.78, traded Jul 20, 2026, filed Jul 21, 2026.
Score components
- +15RoleOfficer
- 0Trade size$4k at market
- +10Share of holdings soldSold 43% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001437749-26-023948, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | AGrant or award Common Stock | +2,150 | $1.83 | $3,935 | 5,046 | Jul 21, 2026 |
| Jul 20, 2026 | SOpen-market sale Common Stock | -2,150 | $1.78 | $3,830 | 2,896 | Jul 21, 2026 |
Related signals
Other insiders at Imunon, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 25Weak | IMNNsell Imunon, Inc. | Susan Eylward General Counsel and Corp Sec | $3,950 2,525 shares | -47% | |
| 25Weak | IMNNsell Imunon, Inc. | Susan Eylward General Counsel and Corp Sec | $3,993 2,449 shares | -46% | |
| 25Weak | IMNNsell Imunon, Inc. | Susan Eylward General Counsel and Corp Sec | $3,977 2,541 shares | -47% | |
| 20Weak | IMNNsell Imunon, Inc. | Susan Eylward General Counsel and Corp Sec | $1,730 920 shares | -24% | |
| 35Weak | IMNNsell Imunon, Inc. | Susan Eylward General Counsel and Corp Sec | $21k 11,800 shares | -80% | |
| 53Moderate | Imunon, Inc. | Donald P Braun director | $29k 25,000 shares | +4188% | |
| 51Moderate | Imunon, Inc. | Michael H Tardugno Executive Chairman of Board | $26k 25,000 shares | +8% | |
| 51Moderate | Imunon, Inc. | Stacy Lindborg President and CEO | $25k 25,000 shares | +10% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.